-
1by Tetsuya Akaishi, Takuhiro Yamaguchi, Yasushi Suzuki, Yuriko Nagane, Shigeaki Suzuki, Hiroyuki Murai, Tomihiro Imai, Masakatsu Motomura, Kazuo Fujihara, Masashi Aoki, Kimiaki Utsugisawa“...Myasthenia gravis (MG) is often categorized into thymoma-associated MG, early-onset MG with onset...”
Published 2014-01-01
Get full text
Article -
2by Tomihiro Imai, Shigeaki Suzuki, Yuriko Nagane, Akiyuki Uzawa, Hiroyuki Murai, Kimiaki UtsugisawaSubjects: “...myasthenia gravis...”
Published 2020-08-01
Get full text
Article -
3by Munenori Oyama, Kensuke Okada, Masayuki Masuda, Yuko Shimizu, Kazumasa Yokoyama, Akiyuki Uzawa, Naoki Kawaguchi, Ryotaro Ikeguchi, Yasunobu Hoshino, Taku Hatano, Yukiko Ozawa, Jin Nakahara, Hitoshi Aizawa, Kazuo Kitagawa, Nobutaka Hattori, Satoshi Kuwabara, Hiroyuki Murai, Shigeaki Suzuki“... antibody-positive refractory generalized myasthenia gravis (gMG). However, there is no consensus regarding...”
Published 2020-03-01
Get full text
Article -
4by Shingo Konno, Shigeaki Suzuki, Masayuki Masuda, Yuriko Nagane, Emiko Tsuda, Hiroyuki Murai, Tomihiro Imai, Toshiki Fujioka, Norihiro Suzuki, Kimiaki Utsugisawa“...To investigate the association between glucocorticoid-induced osteoporosis and myasthenia gravis...”
Published 2015-01-01
Get full text
Article -
5by Hiroyuki Murai, Shigeaki Suzuki, Miki Hasebe, Yuji Fukamizu, Ema Rodrigues, Kimiaki Utsugisawa“...+) generalized myasthenia gravis (gMG) whose symptoms are difficult to control with high-dose intravenous...”
Published 2021-03-01
Get full text
Article -
6by Kristl G Claeys, Renato Mantegazza, Hiroyuki Murai, Francesco Saccà, Sonia Berrih-Aknin, Nancy Law, Sarah Dewilde, Mathieu F Janssen, Emma Bagshaw, Hara Kousoulakou, Mark Larkin, Jon Beauchamp, Trevor Leighton, Sandra Paci“...Introduction Myasthenia gravis (MG) is a rare, chronic, autoimmune disease, mediated...”
Published 2021-07-01
Get full text
Article -
7by Saiju Jacob, Hiroyuki Murai, Kimiaki Utsugisawa, Richard J. Nowak, Heinz Wiendl, Kenji P. Fujita, Fanny O’Brien, James F. Howard“...Background: In the phase III eculizumab for refractory generalized myasthenia gravis REGAIN study...”
Published 2020-04-01
Get full text
Article